ArticleArchives of dermatological research2025
Facial neuromodulator expectations of treatment naïve millennials.
Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As the millennial generation increasingly dominates the consumer landscape of facial neuromodulator treatments, a comprehensive understanding of their perceptions is crucial for tailoring effective aesthetic medical practices. However, there is currently a lack of comprehensive understanding of millennials' knowledge, attitudes, and expectations regarding facial neuromodulator treatments. We aim to understand millennials' perceptions and expectations regarding neuromodulator treatments. We conducted a cross-sectional survey to uncover the perceptions and expectations of millennials towards facial neuromodulator treatments. Of the 150 participants, the primary reasons for considering treatment were the desire to look good for one's age (48%) and to appear more youthful (26%). The main reasons for not pursuing treatment were the belief that it was not yet necessary (57%) and concerns about safety or side effects (11%). Millennials were most interested in treating their forehead (75%), lateral canthal area (49%), and glabella (39%). Expectations varied in terms of treatment outcomes, recovery times, and result duration. Most respondents anticipated a positive impact on self-esteem (52%) and would "probably" or "definitely" disclose undergoing treatments to their friends and peers (65%). Herein, we reveal a complex landscape of millennial understanding of and expectations towards facial neuromodulator treatments. The findings underscore the necessity for physicians to engage in detailed patient education and adapt communication strategies to align with millennial expectations and values. A better understanding of millennials' expectations may guide clinical practices and allow dermatologists to significantly improve patient satisfaction and outcomes, driving forward the field of aesthetic medicine.
Indexed as
Identifiers
40138039What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.